30
/pt/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
2135679
178559
2

16 maio 2018 ano - FDA approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for the mitigation of withdrawal symptoms associated with abrupt discontinuation of opioids.

Adicionado na linha do tempo:

13 nov 2018

Data:

16 maio 2018 ano
Agora
~ 6 years ago